DMCC Specialty Chemicals has announced a key board appointment, naming Ms. Saloni Jhaveri as an independent director. The appointment marks a significant addition to the company's governance structure as it continues to strengthen its leadership team.

Board Appointment Details

The company has provided specific details regarding the new directorship appointment:

Strategic Governance Enhancement

The appointment of Ms. Saloni Jhaveri as an independent director represents the company's commitment to maintaining robust corporate governance practices. Independent directors play a crucial role in providing objective oversight and bringing diverse perspectives to board deliberations.

Future Implementation

With the appointment scheduled to take effect from January 10, 2026, DMCC Specialty Chemicals is planning ahead for its board composition. The five-year term provides stability and continuity for the company's governance framework, ensuring consistent independent oversight during this period.

This board appointment reflects the company's proactive approach to corporate governance and its focus on building a strong leadership foundation for future operations.

DMCC Speciality Chemicals Limited has disclosed the contact details of its Key Managerial Personnel (KMP) in compliance with SEBI regulations. The company informed both NSE and BSE on January 10, 2026, about the Board of Directors' authorization of four key executives for regulatory disclosure purposes.

Board Authorization and Regulatory Compliance

The Board of Directors meeting held on January 10, 2026, authorized specific Key Managerial Personnel for determining materiality of events and information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure ensures compliance with Regulation 30(5) of the SEBI LODR regulations, which mandates companies to provide contact details of authorized personnel for regulatory communications.

Key Managerial Personnel Details

The company has designated four senior executives as authorized KMP for regulatory disclosure purposes:

Leadership Transition

A notable aspect of this disclosure is the appointment of Ms Pallavi Pednekar as Company Secretary & Compliance Officer, with her role commencing from January 27, 2026. This indicates a planned leadership transition in the company's compliance function, ensuring continuity in regulatory oversight and corporate governance.

Corporate Communication Framework

The disclosure establishes a clear communication framework for regulatory matters, with all four KMP sharing the same primary contact number (+91 22 22048882/3) while maintaining individual email addresses for specific departmental communications. This structure facilitates efficient handling of regulatory queries and ensures appropriate escalation channels for material information disclosure to stock exchanges.